[PDF][PDF] Azelnidipine (CS-905), a novel dihydropyridine calcium channel blocker with gradual onset and prolonged duration of action
Y Yagil, A Lustig - Cardiovascular drug reviews, 1995 - academia.edu
CS-905 is insoluble in water. For oral administration under experimental conditions, it has
been suspended in 0.3% carboxymethylcellulose (CMC) solution (5, 7-9) or in a 1 5 mixture …
been suspended in 0.3% carboxymethylcellulose (CMC) solution (5, 7-9) or in a 1 5 mixture …
Novel solvate and crystalline forms of lercanidipine hydrochloride
A Leonardi, G De Iasi, F Bonifacio - US Patent App. 10/214,385, 2003 - Google Patents
The invention describes neW solvates of lercanidipine hydrochloride With organic solvents,
neW lercanidipine hydrochloride crystalline Forrns (III) and (IV) obtained from said solvates …
neW lercanidipine hydrochloride crystalline Forrns (III) and (IV) obtained from said solvates …
[PDF][PDF] An analytical approach of azelnidipine: A review
D Mandale, R Mistry, N Chauhan - World J Pharm Pharm Res, 2021 - researchgate.net
Azelnidipine (AZEL) is chemically (±)-3-(1-diphenylmethylazetidin3-yl) 5-isopropy12-amino-
1, 4-dihydro-6-methyl-4-(3-nitrophenyl) 3, 5-pyridinedicarboxylate. It is a dihydropyridine …
1, 4-dihydro-6-methyl-4-(3-nitrophenyl) 3, 5-pyridinedicarboxylate. It is a dihydropyridine …
[引用][C] A Novel Ultra Performance Liquid Chromatographic Method for the Estimation of Lercanidipine in Bulk and Tablet Dosage Form
S Sahu, U Sunila Kumar Patra, P Kumar Patra - 2021 - JPRI
Crystalline forms of candesartan cilexetil
R bandi Parthasaradhi, R kura Rathnakar… - US Patent …, 2009 - Google Patents
US7504516B2 - Crystalline forms of candesartan cilexetil - Google Patents US7504516B2 -
Crystalline forms of candesartan cilexetil - Google Patents Crystalline forms of candesartan …
Crystalline forms of candesartan cilexetil - Google Patents Crystalline forms of candesartan …
[PDF][PDF] Iraqi Journal of Pharmacy
SS Mahmoud - mosuljournals.com
Background: Cilnidipine, a common hypertension medication, is now being studied for its
potential to improve insulin sensitivity, which plays a key role in regulating blood sugar …
potential to improve insulin sensitivity, which plays a key role in regulating blood sugar …
[PDF][PDF] Determination of cilnidipine from pharmaceutical formulation by high performance thin layer chromatographic method
HS Karmalkar, VV Vaidya, NA Gomes… - Analytical …, 2008 - hakon-art.com
Cilnidipine [1] is a dihydropyridine (DHP) type of calcium channel antagonist. Unlike other
calcium channel antagonists, cilnidipine blocks the influx of Ca2+ ions into both vascular …
calcium channel antagonists, cilnidipine blocks the influx of Ca2+ ions into both vascular …
[PDF][PDF] International Journal of Modern Pharmaceutical Research
TBY RP-HPLC, INPD FORM - ijmpronline.com
An accurate, precise, simple, efficient and reproducible, isocratic Reversed Phase-High
Performance Liquid Chromatography (RP-HPLC) method was developed and validated for …
Performance Liquid Chromatography (RP-HPLC) method was developed and validated for …
Effects of Cilostazol on the Pharmacokinetics of Nifedipine After Oral and Intravenous Administration in Rats
CK Lee, JS Choi, DH Choi - Pharmaceutical Chemistry Journal, 2017 - Springer
The purpose of this study was to investigate the effects of cilostazol on the bioavailability and
pharmacokinetics of nifedipine and its main metabolite, dehydronifedipine, in rats. The …
pharmacokinetics of nifedipine and its main metabolite, dehydronifedipine, in rats. The …